Non-Hodgkin's B-cell Lymphoma
Showing 1 - 8 of 8
Non-Hodgkin's B-cell Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Leukemia Trial in Worldwide (MT-3724
Terminated
- Non-Hodgkin's B-cell Lymphoma
- +5 more
- MT-3724 Phase 1
- MT-3724 Phase 2
-
Tucson, Arizona
- +40 more
Jul 18, 2022
Non-Hodgkin's B-cell Lymphoma Trial in Hangzhou (CD19/CD20-directed CAR-T cells)
Recruiting
- Non-Hodgkin's B-cell Lymphoma
- CD19/CD20-directed CAR-T cells
-
Hangzhou, Zhejiang, ChinaFirst Affiliated Hospital of Zhejiang University College of Medi
Apr 10, 2021
Cancer Diagnosis and Treatment on Everyday Life
Active, not recruiting
- Breast Cancer Female
- +17 more
-
Aberystwyth, United Kingdom
- +110 more
Mar 16, 2021
Non-Hodgkin's B-cell Lymphoma Trial in Tianjin (CD19/CD20-directed CAR-T cells)
Recruiting
- Non-Hodgkin's B-cell Lymphoma
- CD19/CD20-directed CAR-T cells
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Institute & Hosipital
Jan 5, 2021
Non-Hodgkin's B-cell Lymphoma Trial in Beijing (CD19/CD20-directed CAR-T cells)
Recruiting
- Non-Hodgkin's B-cell Lymphoma
- CD19/CD20-directed CAR-T cells
-
Beijing, Beijing/China, ChinaPeking Union Medical College Hospital
Nov 30, 2020
Non-Hodgkin's B-cell Lymphoma Trial in Shanghai (CD19/CD20-directed CAR-T cells)
Unknown status
- Non-Hodgkin's B-cell Lymphoma
- CD19/CD20-directed CAR-T cells
-
Shanghai, Shanghai, ChinaShanghai Tongji Hospital, Tongji University School of Medicine
Sep 23, 2020